Novo Nordisk’s new-generation basal insulin Tresiba® approved in China

News Hour:

Novo Nordisk today announced that the China Food and Drug Administration (CFDA) has approved Tresiba® (insulin degludec) for the treatment of diabetes in China. Tresiba® is a new-generation, once-daily basal insulin with an ultra-long duration of action which allows for flexibility in day-to-day dosing.

Tresiba® provides a significantly lower risk of overall, severe and nocturnal hypoglycemia (low blood sugar) and comparable reductions in blood sugar levels vs. insulin glargine U100 in people with diabetes. Studies have also shown that Tresiba® provides significantly lower variability in blood sugar levels compared to insulin glargine U100 and U300.

“There are more adults with diabetes in China than anywhere in the world, and we are delighted that the CFDA’s approval brings the availability of Tresiba® in China one step closer,” said Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk.


“Tresiba® gives physicians and people with diabetes a new treatment option that provides equivalent reductions in blood glucose levels and significantly lower risk of hypoglycemia.”

In the multinational, double-blinded Tresiba® cardiovascular outcomes trial, DEVOTE, reported earlier this year, Tresiba® demonstrated cardiovascular safety and a reduced rate of severe and nocturnal severe hypoglycemia by 40% and 53% respectively compared to insulin glargine U100 in people with type 2 diabetes.

In the double-blinded SWITCH trials, Tresiba® demonstrated significantly lower rates of overall, nocturnal and severe hypoglycemia vs. insulin glargine U100 in the full treatment period in people with type 1 and type 2 diabetes.

China has over 100 million people living with diabetes, and the number is expected to grow to more than 150 million people by 2040.9 Tresiba® is expected to launch in China in Q1 2018.


This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Waste management an essential public service in the fight to beat COVID-19
Human chain on International Women's Day by SERAC-Bangladesh
Bangladesh will work with UK to fight corona, reiterates PM
HIV and AIDS: Facts and Forewarning in the context of Bangladesh
Juventus players agree to take pay reduction in 90-million-euro cost cut
Vodafone to offer free unlimited mobile data during the Coronavirus pandemic


News of the Month

September 2017
« Aug   Oct »
Scroll Up
%d bloggers like this: